View more on these topics

Neil Woodford to launch biotech investment trust

Neil Woodford is set to launch a new biotech investment trust through his new venture next year.

The FT reports the fund manager is set to roll out the new portfolio in response to the growing number of unquoted biotech firms.

Woodford already invests in Oxford Nanopore, an unquoted UK bioscience firm, through his equity income fund he launched in June, a month after setting up Woodford Investment Management.

He also has a £16m stake in Northwest Biotherapeutics, a US company working on treatments for brain tumours.

It is hoped an investment trust structure would be better suited to the biotech industry because it will provide “permanent capital” to the underlying companies.

Woodford’s existing fund currently has assets of £3.6bn and he also manages a further £5bn of independent mandates including for St James’ Place. 


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm